US2012238621A1
|
|
Oligomer-calcimimetic conjugates and related compounds
|
US2014039020A1
|
|
Oligomer-containing hydantoin compounds
|
US2014296334A1
|
|
N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
|
US2012108501A1
|
|
Protease Inhibitors
|
US2012101145A1
|
|
Oligome-containing pyrrolidine compounds
|
US2012122871A1
|
|
Oligomer-containing substituted aromatic triazine compounds
|
US2012094998A1
|
|
Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
|
US2012071491A1
|
|
Oligomer-protein tyrosine kinase inhibitor conjugates
|
US2012071492A1
|
|
Oligomer-protein tyrosine kinase inhibitor conjugates
|
US2010048602A1
|
|
Oligomer-opioid agonist conjugates
|
US2011112183A1
|
|
Oligome-bis-chromonyl compound conjugates
|
US2012022063A1
|
|
Oligome-cannabinoid conjugates
|
US2010227865A1
|
|
Oligomer-beta blocker conjugates
|
US2010168232A1
|
|
Oligomer-anticholinergic agent conjugates
|